Lisa Chodirker

Overall survival in lower <scp>IPSS</scp> risk <scp>MDS</scp> by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an <scp>MDS</scp>‐<scp>CAN</scp> analysis

Heather A. Leitch, Ambica Parmar, Richard A. Wells et al. · British Journal of Haematology · 2017 · 64 citations · Full text

Medicine, Hematology, Iron Metabolism Disorders +13

Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure

Rosanne St. Bernard, Lisa Chodirker, Esther Masih‐Khan et al. · Bone Marrow Transplantation · 2014 · 57 citations

Medicine, Nephrology, Dialysis +12

An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

Rebecca Starkman, Shabbir M.H. Alibhai, Richard A. Wells et al. · Leukemia · 2019 · 34 citations

Medicine, Clinical Sciences, Geriatric Medicine +17

Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis

Rena Buckstein, Robert S. Kerbel, Matthew C. Cheung et al. · Leukemia Research · 2014 · 20 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study

Abi Vijenthira, D Premkumar, Jeannie Callum et al. · Leukemia Research · 2018 · 17 citations

Medicine, Hematology, Internal Medicine +16